PTIX · Protagenic Therapeutics
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
Market Cap
1.182M
52 Wk Range
$0.13 - $2.71
Previous Close
$0.65
Open
$0.65
Volume
20
Day Range
$0.65 - $0.65
Enterprise Value
2.966M
Cash
2.213M
Avg Qtr Burn
-509.7K
Insider Ownership
6.20%
Institutional Own.
3.69%
Qtr Updated
Dec 31st 2025